Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Current Assets: 2019-2024

Historic Current Assets for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $51.7 million.

  • Benitec Biopharma's Current Assets rose 624.00% to $104.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $104.0 million, marking a year-over-year increase of 624.00%. This contributed to the annual value of $51.7 million for FY2024, which is 1285.73% up from last year.
  • Benitec Biopharma's Current Assets amounted to $51.7 million in FY2024, which was up 1,285.73% from $3.7 million recorded in FY2023.
  • Benitec Biopharma's 5-year Current Assets high stood at $51.7 million for FY2024, and its period low was $3.7 million during FY2023.
  • Moreover, its 3-year median value for Current Assets was $4.8 million (2022), whereas its average is $20.1 million.
  • In the last 5 years, Benitec Biopharma's Current Assets slumped by 76.61% in 2022 and then surged by 1,285.73% in 2024.
  • Over the past 5 years, Benitec Biopharma's Current Assets (Yearly) stood at $10.8 million in 2020, then skyrocketed by 90.66% to $20.6 million in 2021, then slumped by 76.61% to $4.8 million in 2022, then fell by 22.63% to $3.7 million in 2023, then spiked by 1,285.73% to $51.7 million in 2024.